2m 2m 2m 2m 2m 2m 2m
Penumbra (PEN)
NYSE
$317.61+$1.41 (+0.45%)
Price as of Jun 23, 2026 1:49 PM EDT- $12.4BMarket Cap
- 24.26%1-Year Change
- Medical DevicesIndustry
Penumbra (PEN)
$317.61+$1.41 (+0.45%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.4B +17.50% | 1.2B +12.86% | 1.1B +24.95% | 847.1M +13.32% | |
Cost of Revenue | 461.2M +4.92% | 439.6M +16.96% | 375.9M +20.50% | 311.9M +14.59% | |
Gross Profit | 942.4M +24.83% | 755.0M +10.60% | 682.6M +27.55% | 535.2M +12.58% | |
Sales and Marketing Expense | 663.4M +15.58% | 574.0M +13.33% | 506.5M +12.62% | 449.7M +18.87% | |
Research and Development Expense | -89.8M -5.29% | -94.8M +12.27% | -84.4M +6.32% | -79.4M -24.05% | |
Depreciation and Amortization Expense | 17.5M -26.29% | 23.7M -13.04% | 27.3M +12.07% | 24.3M +48.23% | |
Total Operating Expenses | 753.2M +1.00% | 745.7M +22.43% | 609.1M +15.11% | 529.1M +9.58% | |
Operating Profit | 189.2M +1,939.54% | 9.3M -87.38% | 73.6M +1,109.32% | 6.1M +181.08% | |
Interest Income | 16.3M +19.02% | 13.7M +100.59% | 6.8M N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -1.7M N/A | N/A N/A | |
Interest Income and Expense and Net | 16.3M +19.02% | 13.7M +169.17% | 5.1M N/A | 0 N/A | |
Total Nonoperating Income and Expense | 15.9M +36.98% | 11.6M +90.03% | 6.1M +362.10% | -2.3M -40.92% | |
Income before Taxes | 205.1M +882.92% | 20.9M -73.80% | 79.7M +1,946.51% | 3.9M +137.06% | |
Income Taxes | 27.4M +300.15% | 6.9M +160.66% | -11.3M -291.79% | 5.9M +144.91% | |
Extraordinary Items | 83.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 177.7M +1,168.11% | 14.0M -84.59% | 91.0M +4,643.16% | -2.0M -137.89% | |
Net Income from Continuing Operations Applicable to Common | 205.1M +882.92% | 20.9M -73.80% | 79.7M +1,946.51% | 3.9M +137.06% | |
Basic EPS and Net Income | 4.57 +1,169.44% | 0.36 -84.81% | 2.37 +4,840.00% | -0.05 -135.71% | |
Diluted EPS and Net Income | 4.52 +1,155.56% | 0.36 -84.48% | 2.32 +4,740.00% | -0.05 -135.71% | |
Basic Weighted Average Shares | 38.9M +0.74% | 38.6M +0.61% | 38.4M +1.48% | 37.8M +2.93% | |
Diluted Weighted Average Shares | 39.3M +0.06% | 39.3M +0.13% | 39.2M +3.63% | 37.8M -0.10% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 186.9M -42.39% | 324.4M +93.69% | 167.5M +139.75% | 69.9M +17.65% | |
Short-Term Investments | 357.9M +2,175.83% | 15.7M -87.08% | 121.7M +2.99% | 118.2M -39.55% | |
Cash and Cash Equivalents and Short-Term Investments | 544.8M +60.18% | 340.1M +17.62% | 289.2M +53.80% | 188.0M -26.23% | |
Total Current Assets | 1.2B +27.92% | 951.1M +3.90% | 915.4M +21.13% | 755.7M +10.89% | |
Accumulated Depreciation | 76.7M +2.90% | 74.5M +24.88% | 59.7M +24.21% | 48.0M +25.02% | |
Property and Plant and Equipment and Net | 117.4M +87.47% | 62.6M -13.83% | 72.7M +11.81% | 65.0M +10.46% | |
Total Long-Term Assets | 40.7M -0.54% | 40.9M +58.19% | 25.9M +102.30% | 12.8M -1.48% | |
Total Assets | 1.8B +19.13% | 1.5B -1.49% | 1.6B +13.53% | 1.4B +10.18% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 183.1M +15.65% | 158.3M +4.76% | 151.1M +4.29% | 144.9M +17.64% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 12.3M -18.46% | 15.1M +184.59% | 5.3M +62.03% | 3.3M -7.93% | |
Total Liabilities | 398.9M +4.36% | 382.3M +1.30% | 377.4M +1.43% | 372.0M +28.14% | |
Retained Earnings | 237.7M +296.13% | 60.0M -55.51% | 134.9M +207.17% | 43.9M -4.36% | |
Total Stockholders Equity | 1.4B +24.04% | 1.2B -2.38% | 1.2B +18.03% | 998.9M +4.71% | |
Total Shares Outstanding | 39.2M +1.92% | 38.5M -0.49% | 38.7M +1.51% | 38.1M +1.41% | |
Cash Flow | |||||
Cash from Operating Activities | 238.7M +41.66% | 168.5M +73.10% | 97.3M +274.87% | -55.7M -685.78% | |
Capital Expenditures | 63.7M +200.86% | 21.2M +39.24% | 15.2M -21.17% | 19.3M -8.89% | |
Cash from Investing Activities | -404.6M -621.22% | 77.6M +582.86% | -16.1M -129.34% | 54.8M +352.08% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 26.5M +130.49% | -87.0M -636.97% | 16.2M +39.42% | 11.6M +1,290.19% | |
Financials Ratio | |||||
Gross Margin | 67.14% +6.24% | 63.20% -2.00% | 64.49% +2.08% | 63.18% -0.64% | |
Operating Margin | 13.48% +1,635.87% | 0.78% -88.82% | 6.95% +867.76% | 0.72% +171.56% | |
Return on Assets | 10.58% +1,066.09% | 0.91% -85.40% | 6.21% +4,159.05% | -0.15% -129.95% | |
Return on Equity | 13.78% +1,045.83% | 1.20% -85.60% | 8.35% +4,174.54% | -0.20% -130.95% | |
Revenue Growth | 17.50% +36.11% | 12.86% -48.48% | 24.95% +87.41% | 13.32% -60.13% | |
Current Ratio | 6.64 +10.60% | 6.01 -0.82% | 6.06 +16.15% | 5.21 -5.74% | |
Cash Ratio | 1.02 -50.18% | 2.05 +84.88% | 1.11 +129.90% | 0.48 0.00% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow